RxDoctor Payments Data

Vicki Chan, MD

Family Medicine · Highland Heights, KYNPI 1528261914

Payments from drug & device makers

$690in general payments, 2019–2025

Across 19 payments — averaging $36.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi-aventis U.S. LLC$142
  • Pfizer$117
  • Lilly USA, LLC$94
  • E.r. Squibb & Sons, L.L.C.$81
  • Dexcom, Inc.$60
  • Astellas Pharma US Inc$55
  • plus $141 from 8 others

What the payments were for

  • Food & beverage$62390%
  • Education$6710%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$690 in reported general payments places this provider in the 50th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$78,689
Medicare patients
308
Services billed
1,505

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban113$104,441
OzempicSemaglutide37$61,098
JardianceEmpagliflozin42$53,469
XifaxanRifaximin14$41,447
TrulicityDulaglutide28$30,883
XareltoRivaroxaban26$23,879
MounjaroTirzepatide23$22,610
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$22,344
Breztri AerosphereBudesonide/Glycopyr/Formoterol26$20,569
Breo ElliptaFluticasone/Vilanterol22$16,662
Tresiba Flextouch U-200Insulin Degludec13$11,720
MyrbetriqMirabegron16$10,915
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$4,516
Levothyroxine Sodium410$3,967
Rosuvastatin Calcium392$3,950

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$117$104,441113 claims
Lilly USA, LLCTrulicity, Mounjaro$94$53,49251 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$13$41,44714 claims
AstraZenecaBreztri Aerosphere$12$20,56926 claims
Astellas Pharma US IncMyrbetriq$55$10,91516 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Highland Heights

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →